×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
COYA – coya therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
COYA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/19
08:15 am
coya
Coya Therapeutics CEO Dr. Arun Swaminathan Issues Letter to Stockholders
Low
Report
Coya Therapeutics CEO Dr. Arun Swaminathan Issues Letter to Stockholders
11/11
08:09 am
coya
Coya Therapeutics, Inc. (NASDAQ: COYA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
Medium
Report
Coya Therapeutics, Inc. (NASDAQ: COYA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
11/7
09:51 am
coya
Coya Therapeutics, Inc. (NASDAQ: COYA) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $14.00 price target on the stock.
Low
Report
Coya Therapeutics, Inc. (NASDAQ: COYA) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $14.00 price target on the stock.
11/6
08:00 am
coya
Coya Therapeutics Provides a Corporate Update and Reports Unaudited Third Quarter 2024 Financial Results
Medium
Report
Coya Therapeutics Provides a Corporate Update and Reports Unaudited Third Quarter 2024 Financial Results
11/1
08:18 am
coya
Coya Therapeutics Announces Arun Swaminathan, Ph.D. Assumes New Role as Chief Executive Officer [Yahoo! Finance]
Medium
Report
Coya Therapeutics Announces Arun Swaminathan, Ph.D. Assumes New Role as Chief Executive Officer [Yahoo! Finance]
11/1
08:15 am
coya
Coya Therapeutics Announces Arun Swaminathan, Ph.D. Assumes New Role as Chief Executive Officer
Medium
Report
Coya Therapeutics Announces Arun Swaminathan, Ph.D. Assumes New Role as Chief Executive Officer
10/30
09:25 am
coya
Coya Therapeutics, Inc. (NASDAQ: COYA) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $14.00 price target on the stock.
Medium
Report
Coya Therapeutics, Inc. (NASDAQ: COYA) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $14.00 price target on the stock.
10/29
06:30 am
coya
Coya Therapeutics Announces Positive Results of a Double-Blind Study of Subcutaneous Low-Dose Interleukin-2 (LD IL-2) in Alzheimer’s Disease (AD) Presented at the Clinical Trials on Alzheimer’s Disease Conference (CTAD24) in Madrid (Spain)
High
Report
Coya Therapeutics Announces Positive Results of a Double-Blind Study of Subcutaneous Low-Dose Interleukin-2 (LD IL-2) in Alzheimer’s Disease (AD) Presented at the Clinical Trials on Alzheimer’s Disease Conference (CTAD24) in Madrid (Spain)
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/20
05:16 pm
coya
Form S-3 Coya Therapeutics, Inc.
Low
Report
Form S-3 Coya Therapeutics, Inc.
11/14
06:09 pm
coya
Form 4 Coya Therapeutics, Inc. For: Nov 14 Filed by: SNYDER DAVID S
Medium
Report
Form 4 Coya Therapeutics, Inc. For: Nov 14 Filed by: SNYDER DAVID S
11/13
04:06 pm
coya
Form 4 Coya Therapeutics, Inc. For: Nov 13 Filed by: Swaminathan Arun
Medium
Report
Form 4 Coya Therapeutics, Inc. For: Nov 13 Filed by: Swaminathan Arun
11/12
06:04 pm
coya
Form 4 Coya Therapeutics, Inc. For: Nov 11 Filed by: Grossman Fred
Low
Report
Form 4 Coya Therapeutics, Inc. For: Nov 11 Filed by: Grossman Fred
11/12
04:59 pm
coya
Form 4 Coya Therapeutics, Inc. For: Nov 11 Filed by: Swaminathan Arun
Low
Report
Form 4 Coya Therapeutics, Inc. For: Nov 11 Filed by: Swaminathan Arun
11/12
03:38 pm
coya
Form SC 13G/A Coya Therapeutics, Inc. Filed by: VANGUARD GROUP INC
Low
Report
Form SC 13G/A Coya Therapeutics, Inc. Filed by: VANGUARD GROUP INC
11/6
08:07 am
coya
Form 10-Q Coya Therapeutics, Inc. For: Sep 30
Medium
Report
Form 10-Q Coya Therapeutics, Inc. For: Sep 30
11/6
08:02 am
coya
Form 8-K Coya Therapeutics, Inc. For: Nov 06
Medium
Report
Form 8-K Coya Therapeutics, Inc. For: Nov 06
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: